Tuesday, 11 June 2019

Merck's Keytruda wins FDA approval to treat head and neck cancer

Merck & Co Inc said on Tuesday its blockbuster cancer drug Keytruda won approval from the U.S. Food and Drug Administration to treat a type of head and neck cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)